A prospective, randomized, single-blinded, crossover trial to investigate the effect of a wearable device in addition to a daily symptom diary for the Remote Early Detection of SARS-CoV-2 infections (COVID-RED): a structured summary of a study protocol for a randomized controlled trial
SARS-COV-2 감염 (COVID-RED)의 원격 조기 발견을위한 일일 증상 일기 외에 웨어러블 장치의 효과를 조사하기위한 전향 적, 무작위, 단일 맹장, 크로스 오버 시험 : 연구의 구조적 요약.무작위 제어 시험을위한 프로토콜
Update
[키워드] 1:1
addition
adhere
Algorithm
Algorithms
all subject
all subjects
among others
analysed
antibody
Antibody testing
antibody tests
Antigen
antigen tests
approach
asked
assigned
Asymptomatic
asymptomatic individual
asymptomatic infection
average
baseline
blinded
Blinding
can not
capillary blood
Chain Reaction
changes in
Characteristics
cholinergic urticaria
Cohort
collected
Complete
conditions
conducted
consent form
contribute
control condition
COVID-19
COVID-19 infection
COVID-19 vaccination
current
Daily
defined
demographics
described
detect
detection
determine
develop
deviation
diary
dissemination
Early detection
element
eligibility criteria
eligible
End
enrolled
enrolment
evaluate
exclusion
exploratory
feedback
Follow-up
followed by
gold
gold standard
Health
health resource
heart rate
incidence rates
Inclusion
inclusion criteria
individual
individuals
infected individual
infected individuals
infected with SARS-CoV-2
Infection
information
Informed consent
informed consent form
initial
involved
Laboratory
laboratory-confirmed SARS-CoV-2 infection
machine learning
management
maximum
media
medical history
Mobile application
must
nasal swab
National
natural infection
Negative predictive value
Netherland
Netherlands
notification
NPV
number
objective
occur
outcome
pacemaker
parameter
participant
PCR
PCR test
PCR tests
physiological
physiological parameters
polymerase chain
polymerase chain reaction
populations
portal
positive
Positive predictive value
PPV
pre-symptomatic
Predictive value
primary analysis
profession
proportion
Prospective
protocol
provided
public health
Pulse rate
questionnaire
randomization
randomization sequence
Randomized
Randomized controlled trial
Randomly
receive
recommendation
recruited
recruitment
reduce
remote
reported
resident
resource
responsible
resulting
risk
RIVM
Sample size
SARS-CoV-2
SARS-COV-2 infection
SARS-CoV-2 infections
SARS-CoV-2 test
SARS-CoV-2 virus
sensitivity
sequence
sequence 1
Sequence 2
sequences
serology
serology test
serology tests
significantly
skin temperature
Smartphone
social media
specificity
staff
stratified
stratified block randomization
study participation
Study protocol
subject
suffering
supplementary material
Symptom
Symptom diary
Symptoms
target
temperature
test result
tested
the SARS-CoV-2
thought
Transmission
transmissions
Trial
Trial registration
undergo
urticaria
used to evaluate
vaccinated against COVID-19
vaccination
Vaccine
Variability
wearable device
website
Well-being
[DOI] 10.1186/s13063-021-05643-5 PMC 바로가기 [Article Type] Update
[DOI] 10.1186/s13063-021-05643-5 PMC 바로가기 [Article Type] Update